ZNF479-induced MT1 transcriptional repression was restored by silencing DNA methyltransferase 1 (DHMT1), suggesting potential therapeutic strategies for HCC that target the ZNF479/MLL complex/MT1 or related epigenetic factors (Wu et al., 2019). Here, MT1B is linked to hepatocellular carcinoma.